499 related articles for article (PubMed ID: 18405185)
1. Bexarotene plus PUVA plus radiation combination therapy for mycosis fungoides.
Coors E
Dermatol Clin; 2008 Jan; 26 Suppl 1():33-5. PubMed ID: 18405185
[No Abstract] [Full Text] [Related]
2. Bexarotene salvage therapy in a patient with refractory erythrodermic mycosis fungoides after failure on interferon/PUVA and methotrexate.
Dalle S; Thomas L
Dermatol Clin; 2008 Jan; 26 Suppl 1():39-41. PubMed ID: 18405186
[No Abstract] [Full Text] [Related]
3. Treatment of mycosis fungoides with bexarotene and psoralen plus ultraviolet A.
Coors EA; Von den Driesch P
Br J Dermatol; 2005 Jun; 152(6):1379-81. PubMed ID: 15949024
[No Abstract] [Full Text] [Related]
4. Successful treatment of a folliculotropic mycosis fungoides with bexarotene and PUVA.
Krönke A; Schlaak M; Arin M; Mauch C; Kurschat P
Eur J Dermatol; 2012; 22(2):259-60. PubMed ID: 22240623
[No Abstract] [Full Text] [Related]
5. Bexarotene monotherapy for patients with advanced stage mycosis fungoides.
Bachelez H
Dermatol Clin; 2008 Jan; 26 Suppl 1():25-6. PubMed ID: 18405183
[No Abstract] [Full Text] [Related]
6. Treatment of mycosis fungoides with oral bexarotene combined with PUVA.
Stern DK; Lebwohl M
J Drugs Dermatol; 2002 Sep; 1(2):134-6. PubMed ID: 12847736
[TBL] [Abstract][Full Text] [Related]
7. Treatment of refractory stage IV mycosis fungoides with bexarotene monotherapy.
Otremba B
Dermatol Clin; 2008 Jan; 26 Suppl 1():51-2. PubMed ID: 18405188
[No Abstract] [Full Text] [Related]
8. Bexarotene monotherapy for patients with refractory early stage mycosis fungoides.
Stein A
Dermatol Clin; 2008 Jan; 26 Suppl 1():67-70. PubMed ID: 18405191
[No Abstract] [Full Text] [Related]
9. Juvenile mycosis fungoides treated with bexarotene and PUVA.
Rodríguez-Vázquez M; García-Arpa M; González-García J
Int J Dermatol; 2007 Jan; 46(1):99-102. PubMed ID: 17214731
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of bexarotene combined with psoralen-ultraviolet A (PUVA) compared with PUVA treatment alone in stage IB-IIA mycosis fungoides: final results from the EORTC Cutaneous Lymphoma Task Force phase III randomized clinical trial (NCT00056056).
Whittaker S; Ortiz P; Dummer R; Ranki A; Hasan B; Meulemans B; Gellrich S; Knobler R; Stadler R; Karrasch M
Br J Dermatol; 2012 Sep; 167(3):678-87. PubMed ID: 22924950
[TBL] [Abstract][Full Text] [Related]
11. Treatment of mycosis fungoides with denileukin diftitox and oral bexarotene.
Talpur R; Duvic M
Clin Lymphoma Myeloma; 2006 May; 6(6):488-92. PubMed ID: 16796781
[TBL] [Abstract][Full Text] [Related]
12. Bexarotene treatment of late-stage mycosis fungoides and Sézary syndrome: development of extracutaneous lymphoma in 6 patients.
Bouwhuis SA; Davis MD; el-Azhary RA; McEvoy MT; Gibson LE; Knudsen JM; Kist JM; Pittelkow MR
J Am Acad Dermatol; 2005 Jun; 52(6):991-6. PubMed ID: 15928617
[TBL] [Abstract][Full Text] [Related]
13. Poikilodermatous mycosis fungoides.
Farley-Loftus R; Mandal R; Latkowski JA
Dermatol Online J; 2010 Nov; 16(11):8. PubMed ID: 21163159
[TBL] [Abstract][Full Text] [Related]
14. Topical bexarotene for psoralen plus ultraviolet A-induced photodamage.
Deonizio JM; Vaghani SP; Guitart J
J Am Acad Dermatol; 2013 Aug; 69(2):e96-8. PubMed ID: 23866897
[No Abstract] [Full Text] [Related]
15. Folliculotropic mycosis fungoides with CD30+ large-cell transformation in a young woman: beneficial effect of bexarotene.
Mitteldorf C; Stadler R; Bertsch HP; Neumann C
Br J Dermatol; 2007 Mar; 156(3):584-6. PubMed ID: 17300259
[No Abstract] [Full Text] [Related]
16. [Granulomatous mycosis fungoides: combination therapy with bexarotene and PUVA].
Wirtz M; Helbig D
Hautarzt; 2014 Apr; 65(4):274-6. PubMed ID: 24671704
[TBL] [Abstract][Full Text] [Related]
17. Role of radiation therapy in mycosis fungoides refractory to systemic therapy.
de Sanctis V; Persechino S; Fanelli A; Valeriani M; Bracci S; D'Arienzo M; Monarca B; Caperchi C; Raffa S; Enrici RM
Eur J Dermatol; 2011; 21(2):213-7. PubMed ID: 21489904
[TBL] [Abstract][Full Text] [Related]
18. Cerebral involvement as the first extracutaneous manifestation of mycosis fungoides.
de Quintana-Sancho A; Acebo-Mariñas E; Gardeazabal-García J; Aperribay-Esparza A
Actas Dermosifiliogr; 2015 Oct; 106(8):693-5. PubMed ID: 26071909
[No Abstract] [Full Text] [Related]
19. Plaque stage mycosis fungoides treated with bexarotene at low dosage and UVB-NB.
D'Acunto C; Gurioli C; Neri I
J Dermatolog Treat; 2010 Jan; 21(1):45-8. PubMed ID: 19603308
[TBL] [Abstract][Full Text] [Related]
20. Case experience of 308-nm excimer laser therapy compatibility with PUVA and oral bexarotene for the treatment of cutaneous lesions in mycosis fungoides.
Huang J; Cowper S; Moss J; Girardi M
J Drugs Dermatol; 2013 Apr; 12(4):487-9. PubMed ID: 23652902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
